↓ Skip to main content

Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration

Overview of attention for article published in Molecular Cancer, January 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
Published in
Molecular Cancer, January 2014
DOI 10.1186/1476-4598-13-16
Pubmed ID
Authors

Florian Kopp, Adam Hermawan, Prajakta Shirish Oak, Annika Herrmann, Ernst Wagner, Andreas Roidl

Abstract

Tumor spreading is the major threat for cancer patients. The recently published anti-cancer drug salinomycin raised hope for an improved treatment by targeting therapy-refractory cancer stem cells. However, an unambiguous role of salinomycin against cancer cell migration and metastasis formation remains elusive.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
Croatia 1 <1%
Portugal 1 <1%
Brazil 1 <1%
Unknown 106 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 25%
Other 25 22%
Student > Ph. D. Student 13 12%
Student > Master 10 9%
Student > Bachelor 7 6%
Other 16 14%
Unknown 13 12%
Readers by discipline Count As %
Agricultural and Biological Sciences 54 48%
Medicine and Dentistry 12 11%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Biochemistry, Genetics and Molecular Biology 9 8%
Chemistry 8 7%
Other 8 7%
Unknown 12 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2014.
All research outputs
#20,245,139
of 22,772,779 outputs
Outputs from Molecular Cancer
#1,478
of 1,719 outputs
Outputs of similar age
#266,239
of 307,424 outputs
Outputs of similar age from Molecular Cancer
#43
of 48 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,424 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.